Citadel Advisors’s AdaptHealth AHCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$436K Sell
36,600
-310,800
-89% -$3.18M ﹤0.01% 9627
2025
Q4
$3.46M Buy
347,400
+81,100
+30% +$774K ﹤0.01% 4901
2025
Q3
$2.38M Sell
266,300
-75,400
-22% -$698K ﹤0.01% 5709
2025
Q2
$3.22M Buy
341,700
+56,900
+20% +$502K ﹤0.01% 4860
2025
Q1
$3.09M Sell
284,800
-46,500
-14% -$468K ﹤0.01% 4713
2024
Q4
$3.15M Sell
331,300
-14,100
-4% -$143K ﹤0.01% 4756
2024
Q3
$3.88M Buy
345,400
+178,700
+107% +$1.9M ﹤0.01% 4356
2024
Q2
$1.67M Buy
166,700
+68,800
+70% +$699K ﹤0.01% 5660
2024
Q1
$1.13M Buy
97,900
+89,400
+1,052% +$759K ﹤0.01% 6683
2023
Q4
$62K Sell
8,500
-37,300
-81% -$294K ﹤0.01% 11556
2023
Q3
$417K Buy
45,800
+23,000
+101% +$276K ﹤0.01% 8475
2023
Q2
$277K Sell
22,800
-65,000
-74% -$724K ﹤0.01% 9211
2023
Q1
$1.09M Sell
87,800
-64,700
-42% -$1.19M ﹤0.01% 6571
2022
Q4
$2.93M Sell
152,500
-49,300
-24% -$1.04M ﹤0.01% 4780
2022
Q3
$3.79M Buy
201,800
+84,700
+72% +$1.74M ﹤0.01% 4352
2022
Q2
$2.11M Buy
117,100
+99,600
+569% +$1.62M ﹤0.01% 5436
2022
Q1
$281K Sell
17,500
-6,200
-26% -$111K ﹤0.01% 10737
2021
Q4
$580K Sell
23,700
-19,700
-45% -$462K ﹤0.01% 9327
2021
Q3
$1.01M Buy
43,400
+30,700
+242% +$742K ﹤0.01% 8122
2021
Q2
$348K Sell
12,700
-33,000
-72% -$941K ﹤0.01% 10900
2021
Q1
$1.68M Buy
+45,700
New +$1.61M ﹤0.01% 6824

Other funds holding AHCO

Citadel Advisors's AHCO Position: Q1 2026 in Review

Citadel Advisors increased its AdaptHealth (AHCO) stake by 72% in Q1 2026, buying an estimated $553K and bringing the position to 129,106 shares worth $1.54M. The position accounts for ﹤0.01% of the portfolio, ranked #6656.

Citadel Advisors first reported a position in AHCO in Q1 2020 and has held it in 22 quarters since. The position peaked at $13.9M in Q1 2023. 241 funds tracked by Wall St. Rank hold AHCO as of Q1 2026.

  • Citadel Advisors held 129,106 shares of AdaptHealth worth $1.54M as of Q1 2026.
  • Citadel Advisors bought 54,056 AdaptHealth shares in Q1 2026, an estimated $553K.
  • AdaptHealth made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #6656 holding.
  • Citadel Advisors first reported a position in AdaptHealth in Q1 2020 and has held it in 22 quarters since.
  • Citadel Advisors's AdaptHealth position peaked at $13.9M in Q1 2023.
  • 241 funds tracked by Wall St. Rank held AdaptHealth as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.